
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An algorithmic approach for the treatment of severe uncontrolled asthma
Εleftherios Ζervas, Κonstantinos Samitas, Andriana Ι. Papaioannou, et al.
ERJ Open Research (2018) Vol. 4, Iss. 1, pp. 00125-2017
Open Access | Times Cited: 77
Εleftherios Ζervas, Κonstantinos Samitas, Andriana Ι. Papaioannou, et al.
ERJ Open Research (2018) Vol. 4, Iss. 1, pp. 00125-2017
Open Access | Times Cited: 77
Showing 51-75 of 77 citing articles:
Ketone body augmentation decreases methacholine hyperresponsiveness in mouse models of allergic asthma
Madeleine M. Mank, Leah Reed, V. Amanda Fastiggi, et al.
Journal of Allergy and Clinical Immunology Global (2022) Vol. 1, Iss. 4, pp. 282-298
Open Access | Times Cited: 3
Madeleine M. Mank, Leah Reed, V. Amanda Fastiggi, et al.
Journal of Allergy and Clinical Immunology Global (2022) Vol. 1, Iss. 4, pp. 282-298
Open Access | Times Cited: 3
Potential Treatment Options for ACO, Including Biologics: Are There Any Roles of Biologics?
Nobuhisa Ishikawa
Respiratory disease series (2024), pp. 241-258
Closed Access
Nobuhisa Ishikawa
Respiratory disease series (2024), pp. 241-258
Closed Access
Effectiveness and Safety of Bronchial Thermoplasty in Severe Asthma in Clinical Practice in Spain
Luís Puente‐Maestu, Milagros Llanos Flores, Paola Benedetti, et al.
Biomedicine Hub (2018) Vol. 3, Iss. 3, pp. 1-9
Open Access | Times Cited: 3
Luís Puente‐Maestu, Milagros Llanos Flores, Paola Benedetti, et al.
Biomedicine Hub (2018) Vol. 3, Iss. 3, pp. 1-9
Open Access | Times Cited: 3
Eosinophilic asthma with chronic rhinosinusitis/nasal polyps and biologic agents
İnsu Yılmaz
Tuberkuloz ve Toraks (2019) Vol. 67, Iss. 4, pp. 292-299
Open Access | Times Cited: 3
İnsu Yılmaz
Tuberkuloz ve Toraks (2019) Vol. 67, Iss. 4, pp. 292-299
Open Access | Times Cited: 3
Cromolyn, a New Hope for Limited Treatment of Neutrophilic Asthma: a Phase II Randomized Clinical Trial.
Majid Mirsadraee, Zahra Sabbagh Sajadieh, Shadi Ghafari, et al.
PubMed (2019) Vol. 18, Iss. 3, pp. 208-214
Closed Access | Times Cited: 3
Majid Mirsadraee, Zahra Sabbagh Sajadieh, Shadi Ghafari, et al.
PubMed (2019) Vol. 18, Iss. 3, pp. 208-214
Closed Access | Times Cited: 3
Effect of Vitamin D on the Expression Level of the IL-10 and IL-4 in Asthmatic Mice
Yashar Rouhi, Farnoosh Naseri, Elahe Tahmasebi, et al.
Biointerface Research in Applied Chemistry (2020) Vol. 10, Iss. 6, pp. 7077-7084
Open Access | Times Cited: 3
Yashar Rouhi, Farnoosh Naseri, Elahe Tahmasebi, et al.
Biointerface Research in Applied Chemistry (2020) Vol. 10, Iss. 6, pp. 7077-7084
Open Access | Times Cited: 3
Effectiveness of bronchial thermoplasty in patients with asthma exhibiting overweight/obesity and low quality of life
Kenta Nishi, Chie Yoshimura, Kyohei Morita, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 3, pp. 100756-100756
Open Access | Times Cited: 1
Kenta Nishi, Chie Yoshimura, Kyohei Morita, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 3, pp. 100756-100756
Open Access | Times Cited: 1
Tailored Therapy in Severe Asthma: The Importance of Moving beyond a Disease-Centric Approach
Andreas Photiades, Lamprini Vlassi, Chrysoula Kontogianni, et al.
(2023)
Open Access | Times Cited: 1
Andreas Photiades, Lamprini Vlassi, Chrysoula Kontogianni, et al.
(2023)
Open Access | Times Cited: 1
Patient profiling to predict response to bronchial thermoplasty in patients with severe asthma
Satoshi Ano, Norihiro Kikuchi, Masashi Matsuyama, et al.
Respiratory Investigation (2023) Vol. 61, Iss. 6, pp. 675-681
Open Access | Times Cited: 1
Satoshi Ano, Norihiro Kikuchi, Masashi Matsuyama, et al.
Respiratory Investigation (2023) Vol. 61, Iss. 6, pp. 675-681
Open Access | Times Cited: 1
Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences
Agamemnon Bakakos, Νikoletta Ρovina, Stelios Loukides, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 7, pp. 855-870
Closed Access | Times Cited: 2
Agamemnon Bakakos, Νikoletta Ρovina, Stelios Loukides, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 7, pp. 855-870
Closed Access | Times Cited: 2
Selection of Biologics for Severe Type-2 Asthma
İnsu Yılmaz
Journal of Investigational Allergology and Clinical Immunology (2019) Vol. 29, Iss. 5, pp. 399-400
Open Access | Times Cited: 1
İnsu Yılmaz
Journal of Investigational Allergology and Clinical Immunology (2019) Vol. 29, Iss. 5, pp. 399-400
Open Access | Times Cited: 1
Effectiveness of biomarkers and serum parameters in determination allergic asthma and detection of its severity
Suhayla Hamad Shareef, Kawa Amin
Deleted Journal (2020) Vol. 23, Iss. 18
Open Access | Times Cited: 1
Suhayla Hamad Shareef, Kawa Amin
Deleted Journal (2020) Vol. 23, Iss. 18
Open Access | Times Cited: 1
Bloqueo de inmunoglobulina E en el asma grave
Jessica Purizaca-Bazán, José Antonio Ortega‐Martell
Deleted Journal (2020) Vol. 67
Open Access | Times Cited: 1
Jessica Purizaca-Bazán, José Antonio Ortega‐Martell
Deleted Journal (2020) Vol. 67
Open Access | Times Cited: 1
The effect of Teach-back method education on the control of asthma and family care pressure of patients in Iran
Mohammad Imanipour, Zahra Molazem, Mahnaz Rakhshan, et al.
Investigación y Educación en Enfermería (2022) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Mohammad Imanipour, Zahra Molazem, Mahnaz Rakhshan, et al.
Investigación y Educación en Enfermería (2022) Vol. 40, Iss. 1
Open Access | Times Cited: 1
Severe non-atopic asthma: omalizumab can reduce severe asthma exacerbations
L. Melscoet, N. Khayath, Nicolas Migueres, et al.
Journal of Asthma (2022) Vol. 60, Iss. 5, pp. 881-889
Closed Access | Times Cited: 1
L. Melscoet, N. Khayath, Nicolas Migueres, et al.
Journal of Asthma (2022) Vol. 60, Iss. 5, pp. 881-889
Closed Access | Times Cited: 1
On stimulus persistence and human behavior: the stimulus persistence unification theory
Tobore Onojighofia Tobore
Communicative & Integrative Biology (2022) Vol. 15, Iss. 1, pp. 240-252
Open Access | Times Cited: 1
Tobore Onojighofia Tobore
Communicative & Integrative Biology (2022) Vol. 15, Iss. 1, pp. 240-252
Open Access | Times Cited: 1
Protocol, rationale and design of the PHOLLOW cross-sectional and retrospective chart review study to assess the prevalence and characterize the patient profile, clinical features and disease burden of type-2 low severe asthma in routine care settings in Greece
Petros Bakakos, Evangelia Fouka, Petros Galanakis, et al.
Pneumon (2022) Vol. 35, Iss. 4, pp. 1-13
Open Access | Times Cited: 1
Petros Bakakos, Evangelia Fouka, Petros Galanakis, et al.
Pneumon (2022) Vol. 35, Iss. 4, pp. 1-13
Open Access | Times Cited: 1
Real‑life Cretan asthma registry focused on severe asthma: On behalf of ‘The Cretan registry of the use of Biologics in Severe Asthma’
Katerina M. Antoniou, Maria Bolaki, Konstantinos Karagiannis, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 1
Katerina M. Antoniou, Maria Bolaki, Konstantinos Karagiannis, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 1
Biomarkers in Asthma
Fabio Luigi Massimo Ricciardolo, Vitina Carriero, Francesca Bertolini
Elsevier eBooks (2021), pp. 342-351
Closed Access | Times Cited: 1
Fabio Luigi Massimo Ricciardolo, Vitina Carriero, Francesca Bertolini
Elsevier eBooks (2021), pp. 342-351
Closed Access | Times Cited: 1
Quelle biothérapie choisir en fonction des caractéristiques de l’asthme sévère chez l’adulte ?
A. Didier, Laurent Guilleminault
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 5, pp. 612-618
Open Access
A. Didier, Laurent Guilleminault
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 5, pp. 612-618
Open Access
[ASTHMA PREVENTION AND MANAGEMENT GUIDELINE 2018 (SECTIONS FOR ADULTS): FOCUSING ON THE TREATMENT OF SEVERE ASTHMA].
Akio Niimi
PubMed (2019) Vol. 68, Iss. 6, pp. 669-674
Closed Access
Akio Niimi
PubMed (2019) Vol. 68, Iss. 6, pp. 669-674
Closed Access
High-Risk Asthma Clinic: Putting It All Together
Navitha Ramesh, Fernando Holguín, Sandhya Khurana
Respiratory medicine (2019), pp. 297-311
Closed Access
Navitha Ramesh, Fernando Holguín, Sandhya Khurana
Respiratory medicine (2019), pp. 297-311
Closed Access
VII. The therapy of biological agents and bronchial thermoplasty in asthma
Etsuko Tagaya
Nihon Naika Gakkai Zasshi (2019) Vol. 108, Iss. 6, pp. 1156-1162
Open Access
Etsuko Tagaya
Nihon Naika Gakkai Zasshi (2019) Vol. 108, Iss. 6, pp. 1156-1162
Open Access
Asma grave em pacientes adultos e pediátricos
Guilherme Freire Garcia, Evandro Monteiro de Sá Magalhães, Flávio Mendonça Andrade da Silva, et al.
Revista Médica de Minas Gerais (2019)
Open Access
Guilherme Freire Garcia, Evandro Monteiro de Sá Magalhães, Flávio Mendonça Andrade da Silva, et al.
Revista Médica de Minas Gerais (2019)
Open Access
Ketamine for Adults with Severe Asthma Exacerbation: A Systematic Review and Meta-analysis
Fatimah AlShehri, Heetaf Aloqaily, Joud Enabi, et al.
The Journal of Medicine Law & Public Health (2022) Vol. 2, Iss. 1, pp. 91-97
Open Access
Fatimah AlShehri, Heetaf Aloqaily, Joud Enabi, et al.
The Journal of Medicine Law & Public Health (2022) Vol. 2, Iss. 1, pp. 91-97
Open Access